secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001193125-24-157328
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aldeyra annual meeting results: directors elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- Directors Nancy B. Miller-Rich (21.9M for, 12.6M withheld) and Ben R. Bronstein (22.7M for, 11.8M withheld) elected as Class I directors.
- Shareholders ratified BDO USA as independent auditor for FY 2024: 44.1M for, 372.8K against, 186.6K abstain.
- Non-binding advisory vote on named executive officer compensation approved: 31.5M for, 2.9M against, 126.6K abstain, 10.2M broker non-votes.
- Total shares voted: 44,659,863 of 59,414,489 eligible (75.2% quorum).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524157328/0001193125-24-157328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312524157328/d843373d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-157328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer